- 专利标题： CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS
-
申请号： US18027895申请日： 2021-09-21
-
公开(公告)号： US20230374523A1公开(公告)日： 2023-11-23
- 发明人: Steven C. Katz , Bryan F. Cox , David Benjamin Jaroch
- 申请人： TriSalus Life Sciences, Inc.
- 申请人地址： US CO Westminster
- 专利权人： TriSalus Life Sciences, Inc.
- 当前专利权人： TriSalus Life Sciences, Inc.
- 当前专利权人地址： US CO Westminster
- 国际申请： PCT/US2021/051384 2021.09.21
- 进入国家日期： 2023-03-22
- 主分类号： C12N15/117
- IPC分类号： C12N15/117 ; A61K39/395 ; A61K39/39 ; A61P35/00
摘要：
Embodiments of the present invention provide for methods of treating cancer and methods of delivering toll-like receptor (TLR) agonists to solid tumors in the pancreas using a locoregional therapy through the vasculature. In one aspect, the present invention relates to a method of treating pancreatic cancer comprising administering TLR agonists to the pancreas.
信息查询
IPC分类:
